➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Moodys
McKinsey
McKesson
Johnson and Johnson
Medtronic

Last Updated: July 6, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Carnosine


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

What is the drug development status for Carnosine?

Carnosine is an investigational drug.

There have been 13 clinical trials for Carnosine. The most recent clinical trial was a Phase 2 trial, which was initiated on October 1st 2018.

The most common disease conditions in clinical trials are Hyperuricemia, Schizophrenia, and Peripheral Vascular Diseases. The leading clinical trial sponsors are University of Pittsburgh, Stanley Medical Research Institute, and China Medical University Hospital.

There is one US patent protecting this investigational drug and nine international patents.

Recent Clinical Trials for Carnosine
TitleSponsorPhase
Efficacy of Zinc L-Carnosine Mouth RinseUniversity of MilanPhase 3
Carnosine for Peripheral Vascular DiseaseMonash HealthPhase 2
Carnosine for Peripheral Vascular DiseaseMonash UniversityPhase 2

See all Carnosine clinical trials

Clinical Trial Summary for Carnosine

Top disease conditions for Carnosine
Top clinical trial sponsors for Carnosine

See all Carnosine clinical trials

US Patents for Carnosine

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Carnosine   Start Trial Compositions and methods useful for ameliorating age related maladies NestecSA (Vevey, CH)   Start Trial
Carnosine   Start Trial Bioeffective krill oil compositions AKER BIOMARINE ANTARCTIC AS (Stamsund, NO)   Start Trial
Carnosine   Start Trial Dyeing process using a mixture obtained from an aerosol device comprising a glycerolated surfactant, and device therefor L'OREAL (Paris, FR)   Start Trial
Carnosine   Start Trial Platelet-rich plasma derived from human umbilical cord blood BioDlogics, LLC (Cordova, TN)   Start Trial
Carnosine   Start Trial Systems and methods for maintaining breast or udder health   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Carnosine

Drugname Country Document Number Estimated Expiration Related US Patent
Carnosine Australia 2012231351 2031-03-18   Start Trial
Carnosine Brazil 112013023770 2031-03-18   Start Trial
Carnosine Canada 2830476 2031-03-18   Start Trial
Carnosine China 104066342 2031-03-18   Start Trial
Carnosine European Patent Office 2685987 2031-03-18   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Johnson and Johnson
Boehringer Ingelheim
Express Scripts
Baxter
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.